Skip to content
Menu

Atara Biotherapeutics, Inc. ATRA

Full chart Compare
Set alert

Price alert · ATRA

All alert types
6.76 USD +0.42 (+6.55%)

As ofNov 20, 2026, 12:53 PM EST

6.65 Day range 6.65
3.92 52-week range 19.15
YTD
-62.66%
1 year
-48.90%

Revenue & Expenses

Revenue Profit Costs
Gross Profit$99.56MCost of Revenue$21.21MNet Income$32.69MSelling, General & Admin$26.25MResearch & Development$37.45MOther Expenses$3.14MIncome Tax$31.00KRevenue$120.77M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ATRA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
120.77M128.94M8.57M63.57M20.34M
99.56M107.93M-313.00K63.57M20.34M
35.86M-83.44M-276.01M-280.51M-340.46M
32.69M-85.40M-276.13M-228.30M-340.14M
2.57-11.41-65.19-56.00-91.00
ATRA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
8.48M25.18M25.99M93.09M106.28M
20.23M109.10M165.50M376.42M468.13M
58.74M206.38M264.74M249.78M188.51M
51.77M68.92M80.32M88.30M25.52M
-38.50M-97.28M-99.23M126.64M279.61M
ATRA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-50.94M-68.72M-192.98M-270.43M-220.52M
18.15M8.62M123.87M202.96M22.26M
16.10M59.28M2.01M53.08M103.94M
948.00K-246.00K-1.20M90.57M-10.58M
-16.69M-811.00K-67.10M-14.39M-94.32M